Ritesh Narula, MBBS, MS, discusses phase 1 and early phase 2 results of the Eyestem subretinal stem cell study in geographic atrophy, including an 11-letter mean visual acuity gain maintained at 18 months.
Ritesh Narula, MBBS, MS
Advertisement
Articles by Ritesh Narula, MBBS, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: 3 gene therapy programmes for nAMD approaching phase 3 readouts
2
FAQ: What clinicians need to know about OCU410 phase 2 ArMaDa results
3
EURETINA 2026: Real-world evidence on retinal biosimilars
4
EURETINA 2026: How a national registry is mapping inherited retinal disease in Portugal
5